Oncology Central

MAGIC trial infographic – APF530 in three-drug regimen for CINV

0

Following the publication of the results of the Phase III MAGIC trial in Future Oncologyavailable here – we’ve summarized some of the key trial data in the infographic below. Scroll down to learn more about the efficacy of APF530 for the treatment of chemotherapy-induced nausea and vomiting following highly emetogenic chemotherapy.

To view restricted content, please:
Share:

Leave A Comment